Comparative Analysis of National Drug Policies - Second Workshop Geneva, 10-13 June 1996 - EDM Research Series No. 025
(1997; 175 pages) View the PDF document
Table of Contents
View the documentExecutive summary
View the documentI. Introduction
Open this folder and view contentsII. Background on the research project
Close this folderIII. Second workshop
View the document1. Aim and objectives
View the document2. Participants
View the document3. Method of work and proceedings
Open this folder and view contentsIV. Preliminary findings
Open this folder and view contentsV. Conclusions of the workshop and follow-up plans
Open this folder and view contentsAnnex 1: Research proposal
View the documentAnnex 2: List of participants
View the documentAnnex 3: Agenda
View the documentAnnex 4: Questionnaire on NDP performance assessment
Open this folder and view contentsAnnex 5: Achievements of the national drug policies in the 12 countries
View the documentAnnex 6: Consolidated tables
View the documentOther documents in the DAP Research Series
 

2. Participants

The workshop included 26 participants (see List of Participants in Annex 2):

• Researchers from the initial group of countries: Colombia, Guinea, India, the Philippines, Sri Lanka, Viet Nam, Zambia, and Zimbabwe.

• Researchers from countries which joined the research later and implemented the WHO Indicators for Monitoring National Drug Policies and/or the political mapping: Bulgaria, Chad, Mali and Thailand.

• Resource persons to provide technical support in epidemiology and statistics.

• Coordinators from the Action Programme on Essential Drugs (WHO), the Harvard School of Public Health, and the Karolinska Institutet (IHCAR).

Table 2: Background information on the participating countries


Bulgaria

Chad

Colombia

Guinea

India1

Mali

Philippines

Sri Lanka

Thailand

Viet Nam

Zambia

Zimbabwe

Total population (in millions)

8.4

6.6

37.5

6.3

70.5

8.8

68

17.6

59

72.5

9.3

11.5

Life expectancy (years)

70.9

50.3

69

47

60.7F/57.3M

62F/59M2

65

75F/71M2

69.6

65

55F/50M2

61

GNP per capita (US$)

1186

169

1260

450

61

168

952

588

1650

220

350

438

Infant mortality rate (per 1,000)

16.3

145

27.3

136

60

103

56

17.2

25.95

46

123.3

61

Total public drug expenditure per capita (US$)

8.24

0.05

5.35

0.27

0.13

0.14

0.6

1.34

1.573

0.46

na

4.49

Total value of international aid for drugs (cash + kind) (million US$)

0.2

5.2

0

na

0.02

4.8

na

0.5

na

7.2

na

9.25

Total value of local production (ex-factory price) sold in the country (million US$)

66.6

0.2

980

0

657.1

4.9

na

5.5

481.3

87

na

42.6

Total value of drug imports (CIF) (million US$)

29.44

11.6

20

na

na

11.7

171

50

187.3

152

na

44.7

Total number of pharmacies and outlets in the public sector (including health facilities and hospitals that dispense drugs)

1180

na

3250

399

1817

77

363

922

9648

22400

877

1037

Total number of pharmacies and drug outlets in the private sector4

2200

172

13000

199

14703

468

9985

1541

23842

19300

288

922

1Figures for one state (Andhra Pradesh) only
2F = female / M = male
3Ministry of Public Health only
4In many countries, the number of drug outlets is far above the number of pharmacies

Source: Data coming from the country research 1993-1994-1995 (see Annex 6)

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014